X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2013) 2013
oncology (1319) 1319
hematology (1284) 1284
female (1216) 1216
male (1135) 1135
index medicus (1097) 1097
middle aged (1096) 1096
adult (966) 966
transplantation (884) 884
high-dose chemotherapy (829) 829
chemotherapy (765) 765
stem-cell transplantation (724) 724
high-dose melphalan (719) 719
aged (714) 714
transplantation, autologous (682) 682
antineoplastic combined chemotherapy protocols - therapeutic use (641) 641
treatment outcome (632) 632
multiple myeloma (579) 579
immunology (533) 533
high-dose therapy (480) 480
multiple myeloma - therapy (467) 467
hematopoietic stem cell transplantation (452) 452
bone-marrow-transplantation (447) 447
melphalan (438) 438
care and treatment (436) 436
combined modality therapy (433) 433
prognosis (428) 428
stem cells (421) 421
melphalan - administration & dosage (416) 416
cancer (405) 405
bone-marrow transplantation (384) 384
therapy (360) 360
retrospective studies (350) 350
stem cell transplantation (350) 350
survival (335) 335
multiple myeloma - drug therapy (327) 327
disease-free survival (325) 325
adolescent (312) 312
cyclophosphamide (280) 280
hematopoietic stem cell transplantation - methods (278) 278
bortezomib (276) 276
survival analysis (267) 267
antineoplastic combined chemotherapy protocols - administration & dosage (255) 255
survival rate (254) 254
health aspects (253) 253
multiple-myeloma (246) 246
non-hodgkins-lymphoma (246) 246
autologous transplantation (242) 242
research (240) 240
hematopoietic stem cells (231) 231
cyclophosphamide - administration & dosage (220) 220
melphalan - therapeutic use (219) 219
risk factors (214) 214
antineoplastic agents - therapeutic use (213) 213
child (213) 213
remission induction (207) 207
multiple myeloma - mortality (204) 204
antineoplastic combined chemotherapy protocols - adverse effects (202) 202
randomized-trial (200) 200
recurrence (196) 196
follow-up studies (195) 195
transplantation conditioning - methods (189) 189
al amyloidosis (188) 188
diagnosis (187) 187
hematopoietic stem cell transplantation - adverse effects (186) 186
amyloidosis (182) 182
patient outcomes (180) 180
autologous stem cell transplantation (177) 177
dexamethasone (176) 176
etoposide - administration & dosage (174) 174
colony-stimulating factor (170) 170
salvage therapy (168) 168
primary systemic amyloidosis (166) 166
thalidomide (165) 165
trial (165) 165
bone marrow transplantation (160) 160
etoposide (152) 152
dexamethasone - administration & dosage (150) 150
young adult (150) 150
child, preschool (148) 148
medicine, general & internal (148) 148
amyloidosis - therapy (147) 147
lymphoma (145) 145
time factors (141) 141
myeloma (135) 135
transplantation conditioning (135) 135
blood (134) 134
melphalan - adverse effects (127) 127
pharmacology & pharmacy (127) 127
dose-response relationship, drug (126) 126
transplantation, homologous (124) 124
autografts (123) 123
light-chain amyloidosis (122) 122
lymphomas (122) 122
toxicity (120) 120
phase-ii (119) 119
dosage and administration (118) 118
prospective studies (116) 116
total-body irradiation (116) 116
children (115) 115
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2399) 2399
German (22) 22
French (18) 18
Russian (9) 9
Spanish (6) 6
Hungarian (1) 1
Italian (1) 1
Japanese (1) 1
Korean (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 10/2007, Volume 25, Issue 28, pp. 4459 - 4465
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 5/2019, Volume 83, Issue 5, pp. 905 - 910
Journal Article
Cancer, ISSN 0008-543X, 07/2016, Volume 122, Issue 14, pp. 2197 - 2205
Journal Article
Expert Opinion on Pharmacotherapy, ISSN 1465-6566, 07/2017, Volume 18, Issue 11, pp. 1127 - 1136
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2013, Volume 19, Issue 3, pp. 344 - 356
Abstract Melphalan remains the most widely used agent in preparative regimens for hematopoietic stem cell transplantation (SCT). From its initial discovery... 
Hematology, Oncology and Palliative Medicine | Stem cell transplantation | Conditioning regimens | Melphalan | DIAGNOSED MULTIPLE-MYELOMA | BONE-MARROW-TRANSPLANTATION | LONG-TERM OUTCOMES | IMMUNOLOGY | 1ST COMPLETE REMISSION | TRANSPLANTATION | CORD BLOOD TRANSPLANTATION | INTENSITY ALLOGENEIC TRANSPLANTATION | LIGHT-CHAIN AMYLOIDOSIS | ACUTE LYMPHOBLASTIC-LEUKEMIA | NON-HODGKINS-LYMPHOMA | HIGH-DOSE MELPHALAN | HEMATOLOGY | Hematologic Neoplasms - therapy | Myeloablative Agonists - therapeutic use | Myeloablative Agonists - pharmacology | Graft Survival - immunology | Humans | Pyrazines - administration & dosage | Multiple Myeloma - immunology | Transplantation, Autologous | Hematologic Neoplasms - pathology | Melphalan - therapeutic use | Transplantation, Homologous | Thalidomide - analogs & derivatives | Arabinonucleosides - administration & dosage | Multiple Myeloma - therapy | Antibodies, Monoclonal, Humanized - administration & dosage | Melphalan - pharmacology | Boronic Acids - administration & dosage | Transplantation Conditioning - methods | Adenine Nucleotides - administration & dosage | Bortezomib | Antineoplastic Combined Chemotherapy Protocols | Hematopoietic Stem Cell Transplantation | Alemtuzumab | Thalidomide - administration & dosage | Multiple Myeloma - pathology | Hematologic Neoplasms - immunology | Graft Survival - drug effects | Transplantation | Lymphomas | Hematopoietic stem cells | Multiple myeloma | Stem cells | Index Medicus | melphalan | stem cell transplantation | conditioning regimens
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article